Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons...
Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of...
Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-hous...
Swiss firm Ferring Pharmaceuticals has announced that Propess® (dinoprostone) has been approved by the Minister...
POXEL, headquartered France, and with subsidiaries in Japan, is a biopharmaceutical company focused on the development o...
The Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for darolutamide, under th...
Takeda Pharmaceutical Company Limited, headquartered in Japan, is a value-based research-driven biopharmaceutical leader...
Hitachi Chemical Advanced Therapeutics Solutions, LLC, a US subsidiary of Japanese firm Hitachi Chemical Co., Ltd....
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease target...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as share...
Japan based Astellas Pharma Inc. has successfully completed the previously announced acquisition of Audentes Therapeutic...
Japan based Astellas Pharma Inc. has announced that the Third Fermentation Building (provisional name) will be construct...
US based company Charles River has announced a multi-year drug discovery collaboration with Japanese firm Takeda Pharmac...
Japan based Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc. and Adaptimmune Therapeutics...
ASKA Pharmaceutical Co., Ltd. and KinoPharma, Inc., both based in Tokyo, announced that they have entered into...
apceth Biopharma GmbH, a subsidiary of Japan headquartered Hitachi Chemical Co., Ltd. and a leading company for the manu...
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...
Japan based Astellas Pharma Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its supplem...
